Tumor biomarkers, specifically carcinoembryonic antigen (CEA) and CA 19-9, were markedly elevated in the HP cohort (p = 0.009 and p = 0.004, respectively), suggesting that patients in the HP group may have presented with more advanced or aggressive malignancies. Here, CEACAM5 is linked to neoplasm.